Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-06 02:10:21 - browse：95261

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Why Talkspace is targeting Medicare, a tricky market

focus

WSS

Amylyx ALS drug fails large clinical trial

Florida health officials providing scant details on measles cases

How to bring more disabled researchers into academia

Amylyx ALS drug fails large clinical trial

Streamlined flu vaccines recommended by FDA advisory panel

UnitedHealth quietly bought dozens of outpatient centers

leisure time

Wikipedia

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare drug price negotiation hearing pits pharma v Biden admin

The cancer drug shortage isn’t new — and neither are the solutions

Change Healthcare cyberattack prompts Medicare loan program

Trump demands the U.S. pay no more for drugs than other countries … again

Change Healthcare: What is it, why does its cyberattack matter?

Drug repurposing or repositioning? The language matters

The problem with charging patients to message their doctors

The cancer drug shortage isn’t new — and neither are the solutions

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Wikipedia

For AI in health care standards, federal regulators join with industry group

Immune cells and nerve overgrowth may explain recurring UTI pain

Microsoft's Peter Lee: Generative AI could help doctors be more human

Florida health officials providing scant details on measles cases

Streamlined flu vaccines recommended by FDA advisory panel

Change Healthcare payments predicted restored March 15

leisure time

focus

focus

focus